IIM
CELG

Intact Investment Management’s Celgene Corp CELG Stock Holding History

Intact Investment Management’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-4,200
Closed -$388K – 255
2019
Q2 		$388K Sell
4,200
-1,400
-25% -$133K 0.01% 204
2019
Q1 		$528K Buy
5,600
+600
+12% +$52.5K 0.02% 187
2018
Q4 		$321K Hold
5,000
– – 0.01% 195
2018
Q3 		$447K Hold
5,000
– – 0.02% 200
2018
Q2 		$397K Hold
5,000
– – 0.01% 196
2018
Q1 		$446K Hold
5,000
– – 0.02% 178
2017
Q4 		$522K Buy
+5,000
New +$564K 0.02% 154

Other funds holding CELG

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Intact Investment Management's CELG Position: Q3 2019 in Review

Intact Investment Management sold out of Celgene Corp (CELG) in Q3 2019, closing a stake of 4,200 shares — an estimated $388K sold.

Intact Investment Management first reported a position in CELG in Q4 2017 and held it in 7 quarters. The position peaked at $528K in Q1 2019. 1,245 funds tracked by Wall St. Rank hold CELG as of Q3 2019.

  • Intact Investment Management reported no remaining Celgene Corp position as of Q3 2019 after selling out during the quarter.
  • Intact Investment Management sold 4,200 Celgene Corp shares in Q3 2019, an estimated $388K.
  • Intact Investment Management first reported a position in Celgene Corp in Q4 2017 and held it in 7 quarters.
  • Intact Investment Management's Celgene Corp position peaked at $528K in Q1 2019.
  • 1,245 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2019.

Based on Intact Investment Management's 13F filing for Q3 2019, filed 13 Nov 2019.